BamSEC and AlphaSense Join Forces
Learn More

Vertex Pharmaceuticals Incorporated

NASDAQ: VRTX    
Share price (12/20/24): $397.27    
Market cap (12/20/24): $102 billion

Underwriting Agreements Filter

EX-1
from SC 13D 1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 54 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 3.35% Convertible Senior Subordinated Notes Due 2015 Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 47 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 11,500,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 45 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 10,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 43 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 7,500,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.2
from 8-K 46 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 4.75% Convertible Senior Subordinated Notes Due 2013 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 6,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 42 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 9,100,000 Shares of Common Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 39 pages Vertex Pharmaceuticals Incorporated (A Massachusetts Corporation) 11,750,000 Shares of Common Stock Purchase Agreement
12/34/56
EX-1
from S-3 ~50 pages Form of Underwriting Agreement
12/34/56
EX-1
from S-3 ~50 pages Underwriters Agreement
12/34/56